Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators

Details for Australian Patent Application No. 2007238804 (hide)

Owner Merck & Co., Inc.

Inventors Berger, Richard; Edmondson, Scott; Zhu, Cheng; Hansen, Alexa

Agent Spruson & Ferguson

Pub. Number AU-A-2007238804

PCT Pub. Number WO2007/120688

Priority 60/791,962 14.04.06 US

Filing date 10 April 2007

Wipo publication date 25 October 2007

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

C07D 403/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/120688 Priority application(s): WO2007/120688

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238805-Methods of using GPR119 receptor to identify compounds useful for increasing bone mass in an individual

2007238799-Security image coated with a single coating having visualy distinct regions